Skip to main content

Participating in STATIC

Who can join this trial?

As of dd/mm/yyyy, we have xx people recruited onto the trial.

We aim to have 800 patients take part in the STATIC trial. This will be made up of patients who have been treated by the NHS with Ibrutinib as their second or subsequent treatment for their CLL, as well as those who have been treated with Ibrutinib as their first line of treatment in the FLAIR trial.